PMID- 34722773 OWN - NLM STAT- MEDLINE DCOM- 20220124 LR - 20221207 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2021 DP - 2021 TI - Association between Neutrophil Gelatinase-Associated Lipocalin and Fetal Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus. PG - 8383875 LID - 10.1155/2021/8383875 [doi] LID - 8383875 AB - The effect of neutrophil gelatinase-associated lipocalin (NGAL) on fetal hemoglobin (HbF) levels in diabetic patients is rarely investigated. This study is aimed at investigating the possible association between NGAL and HbF levels in type 2 diabetes mellitus (T2DM). A total of 160 patients with T2DM and 61 healthy individuals were evaluated. NGAL, HbF, tumor necrosis factor-alpha (TNF-alpha), interleukin-5 (IL-5), glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), and urine albumin levels were measured. HbF levels were significantly higher in patients with elevated NGAL than in those without elevated NGAL (1.44% versus 0.94%, P = 0.001). High HbF was 2.3 times more prevalent in patients with elevated NGAL than in those without elevated NGAL. In addition, NGAL, TNF-alpha, and IL-5 levels were significantly higher in patients with high HbF than in those with low HbF; however, there was no significant difference in HbA1c and FPG levels between the two groups. HbF was positively correlated with NGAL (r = 0.275, P < 0.001), TNF-alpha (r = 0.256, P < 0.001), and IL-5 (r = 0.212, P < 0.001), but not with HbA1c and FPG. An elevated NGAL level led to a 1.27-fold increase in the prevalence of high HbF (odds ratio: 1.27, 95% CI: 1.03-2.51, and P < 0.001). The diagnostic efficacy of NGAL to identify an elevated HbF level was superior to that of HbA1c (area under the curve: 0.697, 95% CI: 0.609-0.786 versus 0.584, 95% CI: 0.488-0.681, and P = 0.022). In conclusion, enhanced NGAL production may be closely linked to elevated HbF in conjunction with proinflammatory cytokines in patients with T2DM. CI - Copyright (c) 2021 Jong Weon Choi et al. FAU - Choi, Jong Weon AU - Choi JW AUID- ORCID: 0000-0002-3775-6237 AD - Department of Laboratory Medicine, College of Medicine, Inha University, Incheon, Republic of Korea. FAU - Lee, Moon Hee AU - Lee MH AUID- ORCID: 0000-0002-5965-1815 AD - Department of Internal Medicine, College of Medicine, Inha University, Incheon, Republic of Korea. FAU - Fujii, Tatsuyoshi AU - Fujii T AUID- ORCID: 0000-0001-9747-1682 AD - Department of Internal Medicine, Tsukuba University Hospital Mito Clinical Education and Training Center, Mito Kyodo General Hospital, Ibaraki, Japan. LA - eng PT - Journal Article PT - Observational Study DEP - 20211020 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 RN - 0 (Biomarkers) RN - 0 (Cytokines) RN - 0 (Glycated Hemoglobin A) RN - 0 (LCN2 protein, human) RN - 0 (Lipocalin-2) RN - 0 (Lipocalins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9034-63-3 (Fetal Hemoglobin) SB - IM MH - Adult MH - Aged MH - Albuminuria/epidemiology MH - Biomarkers/blood MH - Cross-Sectional Studies MH - Cytokines/blood MH - Diabetes Mellitus, Type 2/blood/*metabolism MH - Diabetic Nephropathies/diagnosis MH - Female MH - Fetal Hemoglobin/*analysis MH - Glycated Hemoglobin MH - Humans MH - Japan MH - Lipocalin-2/*analysis/metabolism MH - Lipocalins/urine MH - Male MH - Middle Aged MH - Tumor Necrosis Factor-alpha/blood PMC - PMC8550827 COIS- The authors declare that they have no conflicts of interest. EDAT- 2021/11/02 06:00 MHDA- 2022/01/27 06:00 PMCR- 2021/10/20 CRDT- 2021/11/01 09:27 PHST- 2021/05/20 00:00 [received] PHST- 2021/10/05 00:00 [revised] PHST- 2021/10/07 00:00 [accepted] PHST- 2021/11/01 09:27 [entrez] PHST- 2021/11/02 06:00 [pubmed] PHST- 2022/01/27 06:00 [medline] PHST- 2021/10/20 00:00 [pmc-release] AID - 10.1155/2021/8383875 [doi] PST - epublish SO - Biomed Res Int. 2021 Oct 20;2021:8383875. doi: 10.1155/2021/8383875. eCollection 2021.